S
Sarkis K. Mazmanian
Researcher at California Institute of Technology
Publications - 161
Citations - 46119
Sarkis K. Mazmanian is an academic researcher from California Institute of Technology. The author has contributed to research in topics: Microbiome & Immune system. The author has an hindex of 68, co-authored 143 publications receiving 36491 citations. Previous affiliations of Sarkis K. Mazmanian include University of Chicago & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Intestinal Intraepithelial Lymphocyte Repertoires are Imprinted Clonal Structures Selected for MHC Reactivity
Stefan A. Schattgen,Jeremy Chase Crawford,Lee-Ann Van de Velde,Hiutung Chu,Sarkis K. Mazmanian,Phil Bradley,Paul G. Thomas +6 more
TL;DR: In this paper, the authors identify characteristic TCR features of induced CD4-, CD8-, and natural-IEL subsets and furthermore describe for the first time the human natural IEL subset.
Journal ArticleDOI
Gut microbiota suppress feeding induced by palatable foods
TL;DR: In this paper , the authors show that Gut microbiota depletion of mice reversibly results in palatable food overconsumption, and that mice exhibit greater motivation to pursue a high-sucrose reward• Colonization with S24-7 and L. johnsonii reduces vancomycin-induced binge eating.
Effect of oral versus injectable disease-modifying therapies on the epigenome-wide DNA methylation and gut microbiota in multiple sclerosis patients
Patrizia Casaccia,Yunjiao Zhu,Egle Cekanaviciute,Justine W. Debelius,Yadira Bencosme,Sarkis K. Mazmanian,Rob Knight,Rachel Kanner,Sneha Singh,Bruce A.C. Cree,Sergio E. Baranzini,I. Katz-Sand +11 more
Journal ArticleDOI
Breathe easy: microbes protect from allergies
TL;DR: A new study shows that pattern recognition of commensal bacteria by B cells reduces allergic inflammation in mice, adding to the mounting evidence for the 'hygiene hypothesis'.
Patent
Regulate gut microbiota to treat neurodegenerative disorders
TL;DR: In this article, methods and compositions that can be used to improve motor deficits and neuroinflammation in subjects in need, for example subjects suffering from neurodegenerative disorders (e.g., Parkinson's disease).